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Abstract Normally, the growth profile of a CHO cell fed-
batch process can be divided into two main phases based on
changes in cell concentration, being an exponential growth
phase and a stationary (non-growth) phase. In this study, an
additional phase is observed during which the cell division
comes to a halt but the cell growth continues in the form of
an increase in cell size. The cell size increase (SI) phase occurs
between the exponential proliferation phase (also called the
number increase or NI phase) and the stationary phase. During
the SI phase, the average volume and dry weight per cell
increase threefold linearly with time. The average mAb spe-
cific productivity per cell increases linearly with the cell vol-
ume and therefore is on average two times higher in the SI
phase than in the NI phase. The specific essential amino acids
consumption rates per cell remain fairly constant between the
NI and the SI phase, which agrees with the similar biomass
production rate per cell between these two phases.
Accumulation of fatty acids and formation of lipid droplets
in the cells are observed during the SI phase, indicating that
the fatty acids synthesis rate exceeds the demand for the syn-
thesis of membrane lipids. A metabolic comparison between
NI and SI phase shows that the cells with a larger size produce
more mAb per unit of O2 and nutrient consumed, which can
be used for further process optimization.
Keywords Chinese hamster ovary (CHO) cell . Fed-batch .
Antibody production . Phase transition .Metabolic flux
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Introduction
Chinese Hamster Ovary (CHO) cells are the predominant host
for the production of therapeutic monoclonal antibodies
(mAbs). At the moment, fed-batch is the most common indus-
trial process for CHO cell cultures, due to its ease of operation
and flexibility. Three different culture phases can normally be
discerned in a fed-batch culture: an exponential growth phase,
a stationary phase, and a death phase (Ahn and Antoniewicz
2011; Sengupta et al. 2011; Carinhas et al. 2013). The transi-
tions between these phases are caused by the changes in cul-
ture conditions (e.g., nutrient depletion and/or waste accumu-
lation). The transition from the growth to the stationary phase
determines the maximum viable cell density (VCD), whereas
the transition from stationary to death phase determines the
culture longevity. These collectively determine the integral
viable cell density (IVCD) which is positively correlated with
the final mAb product titer. A better understanding of the
underlying mechanisms causing these transitions can be used
to develop cultivation processes in which cells grow to higher
densities or to remain viable for a longer period of time, which
both will result in an increased mAb volumetric productivity.
Many studies have compared the metabolic and physiological
states of different CHO cell culture phases. The growth phase
is characterized by higher specific rates of glycolysis and
glutaminolysis and, as a result, also by a higher lactate
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production rate. During the stationary phase, the metabolism
shifts towards a more efficient use of substrates, represented
by a lower metabolic flux through glycolysis, a higher flux
through the TCA cycle, and often the consumption of lactate.
Martínez et al. (2013) showed that a CHO cell line grown in a
batch culture had a six times higher energy efficiency when
consuming lactate as compared to the situation where lactate
was produced. Using isotopic labeling in combination with
metabolic flux analysis, Sengupta et al. (2011) and
Templeton et al. (2013) both reported higher metabolic fluxes
through the pentose phosphate pathway (PPP) and TCA cycle
during the stationary phase as compared to the growth phase
of CHO cell cultures. Furthermore, Templeton et al. (2013)
showed that the high PPP and TCA activities are associated
with peak mAb production. Results from Wahrheit et al.
(2014) suggested that the metabolic shift in different culture
phases of CHO cells is controlled by glycolytic regulation
which affects the intracellular pyruvate availability. Ahn and
Antoniewicz (2013) reported a higher fatty acids biosynthesis
rate than needed by the cells during the stationary phase of
CHO cell cultures. Despite that these studies have contributed
to the fundamental understanding of CHO cell metabolism
and resulted in improved process performances, the mecha-
nisms underlying the phase transition are not yet fully under-
stood, due to the complexity of media and feeds used and the
highly dynamic nature of the current fed-batch processes.
In a previous study on the selection of basal media and
feeds for CHO cell fed-batch cultures (Pan et al. 2017), it
was observed that a cell size increase occurred after the expo-
nential growth phase when ActiCHO feed A/B (GE
Healthcare) was used but not when Efficient feed A, B, and
C (Gibco™) were used. The cell size increase correlated with
higher final product titers. The physiological state of the larger
cells and the cause of the size increase were not clear. The aim
of this paper is to characterize the metabolic changes that
occur upon the cell size increase in order to obtain more in-
sight in the underlying mechanisms that cause the cell size
increase and identify possible implications for process design.
The metabolic changes are characterized in terms of biomass
composition, specific consumption and production rates, and
overall metabolic flux distributions using flux balance analy-
sis (FBA).
Materials and methods
Cell line and pre-culture
A suspension CHOBC® cell clone (BC-P, provided by
Bioceros Holding BV, Utrecht, NL) producing a recombinant
immunoglobulin G1 (IgG1) was used in this study. Cells were
thawed from aworking cell bank andmaintained in ActiCHO-
P medium (GE Healthcare, France) supplemented with 4 mM
glutamine (Gibco™, Paisley, Scotland, UK) and 0.5% Anti-
clumping agent (Gibco™ Paisley, Scotland, UK). 200 μg/mL
Zeocin™ and 5 μg/mL Blasticidin (both from Gibco™,
Grand Island, NY, USA) as selection reagents were added
during the pre-cultures. Cells were maintained in a 125 mL
un-baffled shake flask (Corning, NY, USA) with a 25 mL
working volume in a CO2 (8%) and temperature (37 °C) con-
trolled incubator. The maintained cultures were sub-cultured
every 3 days to 2 × 105 viable cells/mL. The seed train was
scaled up through 2 and 20 L rocking bag systems. During the
seed train scale-up, the medium described above was used but
without the two selection reagents.
Fed-batch process
Triplicate fed-batch cultures were conducted in 10 L bioreac-
tors (Sartorius Stedim Biotech, France) controlled by
BIOSTAT® B-DCU II. Each bioreactor was inoculated with
a starting density of 3 × 105 viable cells/mL at a starting
volume of 5 L. Culture temperature was controlled at 37 °C,
dissolved oxygen (DO) was controlled at 40% by enriched O2
flow, pH was controlled at 7.2 by using base and CO2. From
day 3 onward, feeds were added to each bioreactor daily. First,
the glucose concentration was measured. If the concentration
was lower than 18 mM, a 45% (w/w) glucose solution was
added as one bolus to reach a glucose concentration of 28 mM
in the reactor. Next, 4.5% (v/v) ActiCHO feed A, also contain-
ing about 500 mM glucose amongst other nutrients, and
0.45% (v/v) ActiCHO feed B (both from GE Healthcare,
USA) per culture volume per day were fed to each reactor.
Simethicone antifoam solution was added to each bioreactor
prior to inoculation and during the culture when needed.
Sampling and analysis
For each bioreactor, a 15-mL sample was taken daily before
and after the feed addition. Total cell density, viable cell den-
sity, and cell diameter were measured using a CedexHiRes®
analyzer (Roche, Switzerland). Off-line pH, pCO2, glucose
concentration, lactate concentration, ammonium concentra-
tion and osmolality were measured by a Nova FLEX analyzer
(Nova Biomedical, USA). The remaining sample was spun
down at 3345×g for 15 min and stored at −20 °C for later
analysis. On culture day 4, 7, and 10, biomass samples were
taken from each bioreactor containing 300 million cells per
sample. The samples were spun down at 500×g for 10min and
re-suspended in PBS solution (Lonza, Switzerland). Next, the
viable cell density was measured again, and each sample was
aliquoted into six 15-mL centrifuge tubes with each tube con-
taining 50 million viable cells. The tubes were spun down at
500×g for 10 min again after which the PBS supernatant was
discarded and the wet cell pellets were stored at −20 °C for
later biomass analysis.
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Total soluble cellular protein was determined using Lowry
Bio-Rad DC Protein assay kit (Bio-Rad, NL). Bovine serum
albumin (BSA, Sigma-Aldrich) was used as a reference stan-
dard. The extraction, separation, and quantification of
triacylglyceride (TAG) and polar lipids were performed as
described by Breuer et al. (2013) using the sample preparation
method 2. Lipid droplets in CHO cells were stained with
BODIPY 505/515 (Invitrogen Molecular Probes, Carlsbad,
CA) and visualized using a confocal laser scanning micro-
scope (LSM510; Carl Zeiss, Jena, Germany), as described
by Cooper et al. (2010). Total cellular carbohydrate content
was measured according to the DuBois’method (DuBois et al.
1956). A glucose solution (Sigma-Aldrich) was used as a ref-
erence standard. Cell dry weight (DW) was calculated based
on the difference in weight of the tube with the 50 million
freeze-dried cells and the pre-weighed centrifuge tube itself.
Compositions of the spent medium including extracellular
amino acids, sugars, and organic acids were quantified using
NMR (Spinnovation Biologics BV, Oss, NL). IgG1 titer was
quantified by Protein-A Chromatography (Agilent, 5069–
3639). The N-glycans were quantified by Hydrophilic
Interaction Chromatography (HILIC UPLC). A dextran cali-
bration ladder standard (Waters) solution was used to identify
the glucose unit of the measured N-glycans. Both mAb quan-
tification and N-glycan analysis were developed by
Bioprocess engineering group of Wageningen University.
Average specific metabolic rates
The average specific metabolic rates were calculated for the
NI and the SI phase, respectively. Day 0 and 1 were not con-
sidered in calculating the average specific rates for the NI
phase, due to a metabolic adaptation period just after inocula-
tion. The average specific production rate of antibody was
calculated by averaging the daily specific rates during both
the NI and the SI phases. The following equation is used to
calculate the specific production rate of a compound x, as
described in Pan et al. (2017):
Mx tð Þ−Mx 0ð Þ−V f  C f ¼ qx∙∫
t
0XVCdt ð1Þ
where Mx (mg; mmol) is the total amount of compound x in a
culture, XVC is the number of viable cells in the reactor, Vf
(mm3) is the total volume of feed added, Cf (mM) is the con-
centration of compound x in the feed, and qx (mg·cell
−1·day−1;
mmol·cell−1·day−1) is the cell-specific production rate of the
compound x. When the rates are calculated based on cell vol-
ume, XVC (mm
3) presents the volume of viable cells in a
culture and qx (mg·mm
−3·day−1 or mmol·mm−3·day−1) is the
cell volume-specific production rate of compound x. The av-
erage specific production rates (q) of glucose, amino acids,
and organic acids were obtained from a plot of the total
amount of production/consumption against the total integral
viable cell number (or total integral viable cell volume) using
linear regression. Positive values indicate production while
negative values indicate consumption. The specific cell
growth rate (μNI; day
−1) during the NI (exponential growth)
phase is given by:
μNI ¼
ln
X VC tð Þ
XVC 0ð Þ=t ð2Þ
where XVC is the total number of viable cells in the reactor.
During the SI phase in which the cell concentration is constant
and the cell volume increases linearly with time, the cell-
specific production rate of biomass (qSI; day
−1) is calculated
by:
qSI ¼
M teð Þ−M tsð Þ
te−ts
=XVC ð3Þ
where M(te) andM(ts) are the amounts of biomass in a reactor
at the end (te) and the start (ts) of the SI phase. In principle, the
unit of M is gram dry weight. However, to compare the
growth in the SI phase to the exponential growth in the NI
phase, the amount of biomass is still expressed in cell number
by dividing the dry weight by the dry weight of a cell in the NI
phase. In this way, the specific biomass production rate in the
SI phase can still be compared to the specific growth rate in
the NI phase. The specific growth rate in the NI phase and the
specific biomass production rate in the SI phase are used as
input values for the subsequent flux balance analysis.
Flux balance analysis (FBA) and flux variability analysis
(FVA)
A basic model of CHO cell primary metabolism was devel-
oped starting from an earlier published basic model for mam-
malian cells (Martens and Tramper 2010). The reactions in the
model were cross-checked with the iCHOv1 model (Hefzi
et al. 2016). Several modifications were made based on the
Kyoto Encyclopedia of Genes and Genomes (KEGG) data-
base, the iCHOv1 model, and the measurements done in this
study (ESM 1).
A Chi-square test was used to check whether the nitrogen
balances closed for both phases. The FBA was conducted
using the constraint-based reconstruction and analysis
(COBRA 2.0) Toolbox (Schellenberger et al. 2007), using
MATLAB software (The MathWorks, Inc.). Geometric FBA
(Smallbone and Simeonidis 2009) was performed to find a
unique solution for the underdetermined parts of the metabolic
model. The growth rate was used as an objective function for
the model. The measured cell-specific production rates were
used as inputs for FBA. To study the possible range of flux
values that results in the same optimal growth rate while still
meeting all constraints, flux variability analysis (FVA) was
performed using the COBRAToolbox (ESM 1).
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Results
Cell growth
Based on cell concentration, the growth curve of CHO cells
normally consists of an exponential cell proliferation phase, a
stationary phase, and a death phase. In this study, an additional
cell size increase phase is reported (Fig. 1), resulting in
four phases for this CHO cell fed-batch process being:
(i) A phase in which the cell concentration increases
exponentially (day 0 to 4) and the volume per cell re-
mains constant (the number increase or NI phase). (ii) A
phase in which the cell size increases nearly linear
(R2 = 0.99) in time (day 4 to 8) and the cell concen-
tration stays approximately constant (the size increase or
SI phase). (iii) A short stationary phase (day 8 to 10) in
which the biomass concentration remains approximately
constant and the culture viability is always higher than
80%. (iv) A death phase (day 10 to 12) in which the
viability declines and is always lower than 80%. Since
the observed change from growth in cell concentration
to growth in cell size has not been reported in regular
fed-batch processes and can have consequences for pro-
cess development, this study mainly focuses on the NI
phase and the SI phase.
Metabolites profiles
To identify possible limiting or inhibitory compounds and to
characterize metabolism in the different phases, extracellular
concentrations of substrates and products were measured.
Concentrations of extracellular glucose, lactate, and ammoni-
um are shown in Fig. 2a. The 45% glucose solution is
added on culture day 3, 7, 8, and 10 when the glucose
concentration is lower than 18 mM, as described in
materials and methods. Next to this, the ActiCHO feed
A&B are added daily. On the days other than 3, 7, 8,
and 10, the increases in culture glucose concentrations
were caused by the addition of ActiCHO feed A only.
Using this feeding strategy, the glucose concentration in
each bioreactor stayed above 5 mM throughout the fed-
batch cultures. Furthermore, since the ActiCHO feed A
also contains glucose, the culture glucose concentration
after feeding can be higher than 28 mM. Lactate is
produced during the NI phase (day 0–4) until nearly
30 mM and is consumed at a lower rate during the SI
phase and stationary phase (day 4–10), followed by pro-
duction again during the death phase (day 10–12).
Ammonium concentrations stay constant at values lower
than 5 mM until culture day 7 and start to increase gradually
thereafter up to 15 mM on day 12. Production of formic acid
(up to 7 mM at day 10) and acetic acid (up to 15 mM at day
10) are observed in the cultures (Fig. 2b). Succinic acid is
present in the basal medium and is consumed during the cul-
ture (Fig. 2b). None of the essential amino acids is depleted
during the fed-batch cultures (Fig. 2c). The gradual increase in
their concentrations after day 3 is caused by the feed addition,
since these essential amino acids cannot be made by CHO
cells from the other compounds. Note that for some of the
non-essential amino acids the cell may not be able to synthe-
size them fast enough to support growth making them essen-
tial for a robust process, consequently, they also need to be
present in the medium and feed. For some of the non-
essential amino acids, asparagine, glutamine, and cys-
t(e)ine (cysteine is measured in the form of cystine in
this study) are consumed during the NI phase and are
depleted around day 4 (Fig. 2d). Glutamine, which is
not present in the feed, is produced after day 7.
Cyst(e)ine concentration increases after day 5. The com-
plete set of raw data for the extracellular compounds
and the composition of both feeds can be found in
ESM 2.
Cell-specific rates vs. volume-specific rates
In order to obtain insight into the relationship between cell
volume and the specific consumption and production
rates of nutrients and products, including mAb, their
metabolic rates were calculated and compared in this
section. The rates are calculated on a per cell and per
cellular volume basis for the NI and the SI phase,
respectively.
The average specific mAb productivities calculated based on
cell-volume and cell-number are shown in Fig. 3a. Average spe-
cific productivity expressed per cell is twofold higher (15 com-
pared to 7.5 pg × cell−1 × day−1) in the SI phase compared to the
NI phase. When calculated per cell volume, the specific produc-
tivities in the two phases are not significantly different, indicating
that the mAb productivity of a cell is related to its volume. This
becomes clearer when the productivity per cell is plotted
against the cellular volume, which results in a linear cor-
relation between average cell volume and specific mAb
productivity as shown in Fig. 3c. The specific glucose
consumption based on cell number shows only a slight
decrease (4.5 to 4.1 μmol × 10−6 cells × day−1) from the
NI to the SI phase. The decrease is larger (1.9 to
0.8 μmol × mm−3 × day−1) when the rate is calculated
based on cell volume. Thus, the specific glucose consumption
rate is related more to the cell number and less to the cell
volume. Lactate is produced during the NI phase at a high rate
(3 μmol × 10−6 cells × day−1; 1.3 μmol × mm−3 × day−1)
and is consumed during the SI phase at a much lower rate
(0.25 μmol × 10−6 cells × day−1; 0.05 μmol × mm−3 × day−1)
(Fig. 4). The cell number-specific and cell volume-specific
consumption rates of ten essential amino acids during
the NI and the SI phase are shown in Fig. 5. When
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the consumption rates are expressed based on cell num-
ber, six out of ten essential amino acids do not show a signif-
icant difference between the two phases. However, as the cell
volume increases in the SI phase, the cell volume-specific
consumption rates of all the essential amino acids show sig-
nificant drops. This implies that the consumption of the essen-
tial amino acids is more related to the cell number than to the
cell volume.
Fig. 1 a Total number of viable
cells (×109, solid lines) and total
volume of viable cells (mm3,
dotted lines), and (b) average cell
diameter (μm, solid lines) and
viability (%, dotted lines) of
reactor 1 (closed circles), 2
(closed diamonds), and 3 (closed
squares). Cultures were divided
into a number increase (NI)
phase, a size increase (SI) phase, a
stationary phase, and a death
phase. (c) Cell diameter (μm)
distribution during a representa-
tive fed-batch culture on day 4
(closed squares), 7 (closed dia-
monds), and 10 (closed triangles)
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Biomass composition
The composition of biomass with respect to protein, fatty acids,
carbohydrate, RNA, and DNA is shown in Table 1 as a percent-
age of the cell dry weight (DW). The amino acid composition of
the cellular protein and the fatty acids composition of the lipids
stayed constant during the fed-batch culture (the average values
are given in ESM 3 Table S1 and S2). The cell DW increased
linearly with the cell volume over the culture time, from 770 pg/
cell on day 4 to 2440 pg/cell on day 10 (Table 1). Furthermore,
the relative composition of the biomass shifted during the cul-
tures. The protein content in the biomass decreased from 74.5 to
67% whereas the fatty acid content increased from 7.2 to 10.3%
from culture day 4 until culture day 10. A microscopic image
(Fig. 6) shows a clear accumulation of lipid droplets during the SI
phase. These droplets are not composed of triacylglyceride
(TAG) (data not shown). The sum of all biomass components
adds up to around 90% of the cell DW.
Flux balance analysis
Geometric flux balance analysis (FBA) is carried out to further
investigate the shift of the overall metabolic flux distribution
from the NI phase to the SI phase. The FBA results for both
phases are summarized in Fig. 7. The metabolic fluxes are
expressed per cell because the uptake rates of essential amino
acids and glucose and the biomass formation rate are constant
on a per cell basis in the NI and SI phase. On a per volume
basis rates are continuously decreasing during the SI phase
due to the increase in cell volume. During the SI phase, the
change in biomass content per cell and in biomass composi-
tion is considered in the biomass equation in the FBA model.
The flux variability analysis (FVA) shows that the flux vari-
ability results in overlapping flux values with respect to the
two different phases for the PPP as well as for the TCA cycle,
as indicated by the red numbers in Fig. 7. This means the value
of these fluxes cannot be identified as being different between
the two phases, which is further addressed in the discussion.
During the NI phase, high fluxes through lactate and alanine
production are calculated. During the SI phase, lactate meta-
bolic flux shifts to a consumption and the flux from pyruvate
to alanine decreases. Higher O2 consumption and CO2 pro-
duction fluxes (~1.5-fold higher) are calculated for the SI
phase, which agrees with the higher ATP generation flux in
the mitochondria. The ATP is transported to the cytosol
through ATP/ADP translocases and used for biomass and
Fig. 2 a Extracellular glucose (solid lines), lactate (dotted lines with
closed marks), and ammonium (dotted lines with open marks)
concentrations (mM) of reactor 1 (circles), 2 (diamonds), and 3 (squares).
(b) Extracellular concentrations of measured organic acids. (c)
Extracellular concentrations of essential amino acids. (d) Extracellular
concentrations of non-essential amino acids. Feeding started on day 3.
For glucose, lactate, and ammonium, samples were taken daily before and
after feed addition. For the other organic acids and amino acids, samples
were taken daily before feed addition. Error bars for all graphs indicate the
standard deviation for the triplicate bioreactors
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product synthesis, and for cell maintenance. The cellular pro-
tein formation rate decreases by 25% whereas the mAb for-
mation increases by 250% during the SI phase. In the NI
phase, mAb production is about 1.5% of the total protein
synthesized, whereas in the SI phase this becomes 5%. In
the SI phase, the fatty acids synthesis flux is slightly higher
and the flux from AcCoA to acetic acid is also higher than in
the NI phase. For the complete result of FBA and FVA, see
ESM 1.
mAb N-glycan composition
The glycosylation profile of a mAb is routinely analyzed
throughout process development to ensure process
Fig. 3 a Average cell number-
specific (pg × cell−1 × day−1) and
average cell volume-specific
(g × L−1 × day−1) mAb produc-
tivity compared between the
number increase (NI) and size in-
crease (SI) phase of the cultures.
*: significantly different
(P < 0.05). b Total mAb produced
(g) in reactor 1 (closed circles), 2
(closed diamonds), and 3 (closed
squares). c Plot of specific mAb
productivity (pg × cell−1 × day−1)
against cell volume (μm3).
Calculation was done per day
from day 2 through day 12. Error
bars of graph (a) and (c) show the
standard deviation of triplicate
fed-batch cultures. Error bars of
graph (b) show the standard de-
viation of triplicate measurements
for each fed-batch culture
Fig. 4 (a) Cell number-based
specific rates (μmol × 10−6
cells × day−1) and (b) cell volume-
based specific rates
(μmol × mm−3 × day−1) of glu-
cose consumption and lactate
production/consumption during
the number increase (NI) and size
increase (SI) phase of the fed-
batch cultures. Positive values in-
dicate production and negative
values indicate consumption.
Error bars show the standard de-
viation of triplicate fed-batch cul-
tures. *: significantly different
(P < 0.05)
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consistency. In order to investigate whether or not the mAb
glycosylation changes as cell size increases, the N-
glycan composition of the produced mAb is measured
on culture day 5, 8 and 12 (Fig. 8). The relative com-
position of N-glycans does not show differences be-
tween culture day 5 and 8, indicating that the mAb
glycosylation does not change as cell size increases.
Differences on day 12 are observed which is most likely
related to cell death and release of degradative enzymes,
since the culture viability drops to 60% on day 12.
Discussion
In this study using ActiCHO medium as basal medium and
Actifeed A and B as feeds, a cell size increase phase was
observed during which the cell concentration remained ap-
proximately constant, while the cell volume increased almost
three times. A previous study (Pan et al. 2017) showed that the
cell size increase in CHO fed-batch processes is clone and
medium/feed dependent. Furthermore, an experiment with
the same process and medium system but with a lower feed
Fig. 5 a Cell number-specific consumption rates (μmol × 10−6
cells × day−1) and (b) Cell volume-specific consumption rates
(μmol × mm−3 × day−1) of essential amino acids during the number
increase (NI) and size increase (SI) phase of the fed-batch cultures.
Error bars show the standard deviation of triplicate fed-batch cultures.
*: significantly different (P < 0.05)
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addition rate, the same extent of cell size increase was ob-
served (data not shown), implying that the cell size increase
is not merely caused by nutrient oversupply. However, several
non-essential amino acids were depleted around day 4 (Fig.
2d), which might play a role in the metabolic transition from
the NI to the SI phase.
The cell diameter distribution during the fed-batch cultures
(Fig. 1c) showed that the increase in cell diameter occurred for
the whole cell population instead of only a sub-population. It
was also established in this study that the cell size increase is
due to a proportional increase in biomass content (Table 1),
rather than due to a cell swelling effect through the uptake of
water and salts. The cell DW measurement resulted in higher
values (770 pg/cell or higher) than commonly reported for
CHO cells (300–400 pg/cell) (Altamirano et al. 2001; Niklas
et al. 2011; Martínez et al. 2015). This can be explained by the
larger cell size (17 μm diameter on day 4) of the CHO cell line
used in this study, compared to those reported (12–14 μm
diameter) (Martínez et al. 2015). We applied the same DW
measurement for another cell line with an average cell diam-
eter of 14 μm at a viability higher than 90%, which resulted in
~330 pg/cell (data not shown). Furthermore, the amino acid
composition of the cellular protein and the fatty acids compo-
sition of the lipids analyzed in this study (ESM 3 Table S1 and
S2) are comparable to those reported for other CHO cells
(Berlin et al. 1996; Selvarasu et al. 2012). With respect to
the content of protein, lipids, carbohydrates DNA, and
RNA, such data could not be found in or derived from CHO
cell studies and therefore, a comparison to the biomass com-
position of hybridoma cells (Xie and Wang 1994; Bonarius
et al. 1996) is shown (Table 1). As can be seen, the composi-
tions are more or less comparable.
The results for the CHO cell line used in this study show
that the mAb specific productivity is directly proportional to
the cell volume (Fig. 3a, c), and further confirm that the mAb
glycosylation profile does not change as the cell size increases
Table 1 CHO cell biomass composition during the fed-batch cultures
Biomass composition Day 4 Day 7 Day 10 Hybridoma (Xie
and Wang 1994)
Hybridoma (Bonarius
et al. 1996)
Protein (%) 74.5 ± 1.0 70.0 ± 1.2 67.0 ± 1.0 72.9 70.6
Fatty acids (%) 7.2 ± 0.2 8.4 ± 0.3 10.3 ± 0.1 13.5 b 9.7 b
Carbohydrate (%) 4.0 ± 0.1 3.8 ± 0.2 4.1 ± 0.1 3.5 7.1
RNA a (%) 6.0 5.6 5.4 3.8 5.8
DNA a (%) 1.6 0.8 0.6 1.4 1.4
Total (%) 93.1 ± 1.4 88.6 ± 1.7 87.4 ± 1.2 95.1 94.6
Cell dry weight (pg/cell) 770 ± 47 1530 ± 77 2440 ± 86 250 470
Cell volume (mm3/106 cells) 2.7 ± 0.02 5.5 ± 0.16 6.9 ± 0.14 N/R 1.8
All percentage values are in w/w %
aNot measured in this study, data were calculated by assuming a constant DNA content per cell and a constant ratio of RNA to protein
b Values for lipid including glycerol
± Standard deviation for biological triplicates
N/R not reported
Fig. 6 Lipid droplets stained
with BODIPY 505/515 (green)
during the CHO cell fed-batch on
culture day 3 (a) and culture day 6
(b)
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(Fig. 8). This is in agreement with Lloyd et al. (2000) who
argued that the cell size is the major cellular determinant of
productivity rather than the cell cycle phase. In addition to
this, Edros et al. (2014) and Khoo and Al-Rubeai (2009)
showed that the increase in specific productivity is directly
related to the increase in cell volume due to increase in tran-
scription, translation, and secretion machinery. Kim et al.
(2001) reported that the enhancement of the specific
thrombopoietin productivity is linearly correlated with the in-
crease in cell size for nine CHO cell clones generated using
the same transfection process. In a number of studies the re-
lation between cell size and specific productivity was used to
enhance mAb productivity, by directly or indirectly increasing
the cell size, for example, through cell cycle arrest (Carvalhal
et al. 2003; Bi et al. 2004), hyperosmotic pressure (Sun et al.
2004; Kiehl et al. 2011), and mild hypothermia (Tait et al.
2013; Martínez et al. 2015).
Acetic acid and formic acid accumulation were observed
during the cultures (Fig. 2b and ESM 3 Fig. S1). Possibly the
acetic acid is formed from acetyl-CoA by one of the
thioesterases that may be present in CHO cells (Bernson
1976). This is further supported by the formation of isovaleric
acid during the SI phase (Fig. 2b), which is formed from
isovaleric acid-CoA as a breakdown product of leucine
(Tanaka et al. 1966) and also requires the activity of an ester-
ase. The formic acid concentration in this experiment reached
4 mM on day 5 (Fig. 2b), which concentration was shown to
inhibit CHO cell growth (Ihrig et al. 1995). Formic acid is
considered a breakdown product of serine (Carinhas et al.
2013; Duarte et al. 2014). In the present study, formic acid is
mainly produced by the breakdown of serine through folate
metabolism (ESM 1), which is also reported by Carinhas et al.
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Fig. 8 Relative mAb N-glycan composition (%) of the 10 L cultures. N-
glycans with different numbers of terminal residuals (G: galactose, F:
fucose, S: sialic acid) are shown. Error bars show the standard deviation
of the triplicate runs. *: significantly different (P < 0.05)
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(2013) and Duarte et al. (2014) and a small fraction is gener-
ated in the breakdown of tryptophan and during synthesis of
cholesterol (ESM 1). The high breakdown rates for some ami-
no acids are likely caused by the overfeeding of these nutrients
after the NI phase as can be seen in Fig. 2. In addition, lactate
concentration showed a peak at 30 mM at around the point
where the transition from the NI to SI phase occurred (Fig. 2).
However, the lactate concentration in this study is not expect-
ed to be the trigger of the phase transition, since the cell clone
used in this study was observed to be able to grow in cell
concentration at a lactate concentration up to 40 mM (data
not shown).
During the SI phase, the slightly higher fatty acids synthe-
sis fluxes (Fig. 7) occurred together with the formation of lipid
droplets (Fig. 6). Formation of lipid droplets has been reported
in CHO cells (Liu et al. 2004). In addition, high fatty acids
synthesis rate during stationary phase was previously reported
in a CHO cell study using 13C isotopic tracers (Ahn and
Antoniewicz 2013). However, the fate of the excessive fatty
acids was unclear in that study. We hypothesize that the accu-
mulation of lipids in the present study is mainly caused by a
maintained fatty acids synthesis rate in combination with a
decreased membrane lipid demand during the SI phase. A
slight increase in the fatty acid synthesis flux from the
NI (0.07) to the SI (0.09) phase (Fig. 7) is observed.
The amount of extra NAD(P)H needed for this is neg-
ligibly small compared to the total NAD(P)H oxidation
flux. The slight increase in the fatty acid synthesis flux,
therefore, is not expected to largely affect the overall
redox rearrangement and through this play a role in
the change in lactate metabolism.
Metabolic patterns of cell size increase
Based on FVA, higher O2 consumption and oxidative phos-
phorylation fluxes were calculated in the SI phase as com-
pared to the NI phase. This results in a higher ATP synthesis
flux during the NI phase, which is reflected in the higher ATP
translocation flux frommitochondria to cytosol in the SI phase
(Fig. 7). The higher flux through oxidative phosphorylation
means that more NADH is generated in the SI phase. The
NADH can be generated in glycolysis and the TCA cycle or
by the combined activity of the PPP and transhydrogenase
systems. However, the fluxes in these pathways cannot be
independently calculated (shown by the red flux values in
Fig. 7) and thus it remains unknown whether the increased
O2 consumption and oxidative phosphorylation activity are
due to an increase in TCA flux or an increased flux through
the PPP or both. Bi et al. (2004) reported a significant increase
in mitochondrial activity (1.6-fold) and mitochondrial mass
(twofold) for a CHO cell line with a similar cell volume in-
crease (three- to fourfold). Furthermore, Zagari et al. (2013)
showed that the lactate metabolism shift from production to
consumption was correlated with higher mitochondrial activ-
ity. The same lactate metabolic shift also occurred in the SI
phase of our study, which also may point to an increase in
TCA cycle activity during the SI phase. These studies support
that the increased NADH generation flux during the SI phase
is mainly generated from a higher flux through the TCA cycle.
However, Sengupta et al. (2011) and Templeton et al. (2013)
showed by using isotopic labeling that the flux through both
the oxidative PPP as well as through the TCA cycle increased
during the non-growth phase. In addition, Ahn and
Antoniewicz (2011) reported a significant increase in oxida-
tive PPP together with a constant TCA flux from the growth
phase to the stationary phase. However, in these last three
studies, the increase in cell size was not reported and thus
the metabolic condition of the non-growth phase in their stud-
ies may not be fully illustrative for the SI phase of this study.
In conclusion, increased O2 consumption and oxidative phos-
phorylation fluxes are calculated and it seems most likely that
an increased TCA cycle flux is the cause for the faster NADH
generation in the SI phase.
The increased NADHdemand and likely higher TCA cycle
activity to generate this NADH could result in a lower NADH/
NAD ratio and a lower pyruvate concentration in the cell. This
might be related to the metabolic switch from lactate produc-
tion to consumption, since the conversion of lactate to pyru-
vate generates NADH and the pyruvate that is generated can
support the higher TCA flux. The higher flux through oxida-
tive phosphorylation may have two causes: (i) a higher energy
demand of cells in the SI phase for maintenance and/or
growth. This may be directly related to cell size, but may also
be related to other factors that change over time like for ex-
ample the ammonium concentration. The energy requirement
for maintenance can increase when cells are exposed to am-
monium due to its competitive inward transport over potassi-
um ions via the Na+/K+-ATPase and the Na+K+2C1−
cotransporter (Martinelle and Häggström 1993). However,
the ammonium is not likely to cause an increase in energy
demand since its concentration remains reasonably constant
between the NI and SI phase. (ii). A decrease in mitochondrial
efficiency by uncoupling of the oxidative phosphorylation. An
Buncoupler^ (i.e., leaky membrane) enables protons to flow
back without passing through the ATP synthase, therefore,
less ATP is generated from the same amount of NADH and
FADH2 (i.e., a lower P/O ratio) (Terada 1990). If the demand
for ATP stays the same, a higher flux through oxidative phos-
phorylation and a higher O2 consumption rate are needed to
meet this demand. The thioesterases responsible for the pro-
duction of acetic acid and isovaleric acid as mentioned before
may also be responsible for the release of free fatty acids that
are known to uncouple the oxidative phosphorylation
(Pressman and Lardy 1956; Skulachev 1991). The slightly
higher fatty acids synthesis fluxes during the SI phase could
be related to this.
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Implications of cell size increase during a culture process
The results of this study stress that cell size and the amount of
biomass per cell should be taken into account during the pro-
cess characterization. Based on cell density measurement
alone, the threefold increase in biomass observed in this work
would not have been captured (Fig. 1), and the cell size in-
crease phase would have been mistakenly identified as part of
the stationary phase. In fact, a two-micron increase in cell
diameter, for instance, from 14 to 16 μm, may already
lead to a 50% increase in total cell volume or biomass.
Furthermore, it can skew the process interpretation such
as final biomass concentration reached, mAb productiv-
ity, and cellular metabolism. Similarly, skewed biologi-
cal interpretation of a transcriptomic study due to cell
size changes was reported by Fomina-Yadlin et al.
(2014). The occurrence of cell size increase is also im-
portant for feed development. Since biomass continues
to grow after the exponential cell concentration increase
phase, the nutrients provided to the culture should con-
tain not only nutrients assigned for maintenance and
mAb production reactions, but also all the precursors
and building blocks for biomass growth. In this specific
culture process, a simple feeding concept would be to
keep the feeding rate of essential amino acids at a per
cell level the same during the SI phase and the NI
phase, since the cell number-specific consumption rates
remain fairly constant (Fig. 5a).
The present study further shows that during the SI phase
the average mAb production per cell increased by a
factor 2 (Fig. 3), while the average O2 consumption
and CO2 production increased only by a factor 1.5
(Fig. 7). In addition, compared to the NI phase, during
the SI phase a higher proportion of the amino acids
taken up from the medium is used for mAb synthesis
(Fig. 7). Collectively, the amount of mAb production
per mol of oxygen and amino acid consumed increases
for larger cells, which can be used for further process
optimization. Especially for high-density perfusion pro-
cesses where O2 and/or CO2 transfer may be limiting, it
may be favorable to have larger cells.
This study demonstrates that cell size is an important factor
for characterizing and optimizing a cell culture process.
Correlations between the cell size increase and metabolic
changes were found. However, further research is needed to
understand the relationship between changes in cell size and
changes in metabolism. In addition, studies on the cellular
pathways that control cell size, such as the mammalian target
of rapamycin (mTOR) pathway (Rohde et al. 2001; Fingar
et al. 2002), and the extracellular stimuli involved could pro-
mote mechanistic understandings for the cell size in-
crease, and enable controlled cell size manipulation dur-
ing a culture process.
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